BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2001
View Archived Issues
GlaxoSmithKline updates R&D activities --merger makes way for robust pipeline
Read More
NIH licensing opportunity: simian-human HAV chimeras
Read More
NIH licensing opportunity: novel antimalarial naphthylisoquinoline alkaloid compounds
Read More
Method of producing water-soluble aminoflavone analogues available for licensing from NIH
Read More
St. Jude and GlaxoSmithKline awarded grant for multidrug-resistant tuberculosis research
Read More
Maxygen and IAVI to develop novel AIDS vaccines
Read More
Positive quality-of-life and survival results reported for Maxim's Ceplene
Read More
BioMarin reports product development update
Read More
2000 achievements at Corixa discussed
Read More
U.S. researchers design chaperone-binding antifibrillogenic peptide
Read More
Inhibition of caspase 2 or 3 may be beneficial in cerebral vasospasm following SAH
Read More
FDA Antiviral Drugs Advisory Committee recommends approval of Roche's valganciclovir
Read More
Interneuron's PRO-2000 to enter phase II/III NIH-supported HIV prevention trial
Read More
FDA grants approval for Reminyl as treatment of Alzheimer's disease
Read More
SeMet induces cell cycle alterations, growth inhibition and apoptosis in colon cancer cells
Read More
BACE1-deficient mice exhibit normal phenotype although beta-amyloid generation is abolished
Read More
InKine cleared to proceed with Colirest pivotal trial for treatment of Crohn's disease
Read More
Neurotrophic agents emerge en masse from Vertex pipeline
Read More
Kaneka isolates and synthesizes new steroid glycosides with antitumor activity
Read More
Selective Y5 receptor antagonists identified in Synaptic/Novartis collaboration
Read More
Japanese patent issued to Santen for new agents for glaucoma
Read More
Endothelial function improved by ETA antagonist in CHF patients
Read More
NeoPharm's CRADA agreement for IL-13 receptor research extended
Read More